1. Home
  2. OPK vs IART Comparison

OPK vs IART Comparison

Compare OPK & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPKO Health Inc.

OPK

OPKO Health Inc.

HOLD

Current Price

$1.10

Market Cap

921.2M

Sector

Health Care

ML Signal

HOLD

Logo Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation

HOLD

Current Price

$14.11

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPK
IART
Founded
2006
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
921.2M
1.1B
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
OPK
IART
Price
$1.10
$14.11
Analyst Decision
Hold
Hold
Analyst Count
3
7
Target Price
$1.60
$14.33
AVG Volume (30 Days)
2.1M
1.1M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$606,879,000.00
N/A
Revenue This Year
N/A
$4.39
Revenue Next Year
$4.24
$3.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.98
$8.70
52 Week High
$1.60
$16.42

Technical Indicators

Market Signals
Indicator
OPK
IART
Relative Strength Index (RSI) 38.47 66.47
Support Level $0.98 $12.64
Resistance Level $1.25 $14.38
Average True Range (ATR) 0.04 0.85
MACD -0.00 0.24
Stochastic Oscillator 52.69 79.73

Price Performance

Historical Comparison
OPK
IART

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.

Share on Social Networks: